Overview:
SAFEHEART 1.25 TABLET, a pivotal product in the Cardiac Care category, is specifically formulated for dogs suffering from Congestive Heart Failure (CHF). Comprising the active ingredient Pimobendan, this medication is essential in managing heart-related conditions such as Dilated Cardiomyopathy (DCM) and Myxomatous Mitral Valve Disease (MMVD). By offering SAFEHEART, upholds its commitment to providing top-tier veterinary products and services, ensuring a better quality of life for our canine companions.

Ingredients:

Pimobendan: This primary ingredient is a benzimidazole-pyridazinone derivative, renowned for its efficacy in managing CHF resulting from DCM or degenerative mitral valve disease. As a phosphodiesterase inhibitor, Pimobendan is instrumental in boosting cardiac function, improving exercise tolerance, and enhancing breathing capabilities in dogs. It strengthens the hearts ability to contract and dilates blood vessels, thus facilitating more effective blood circulation.